What are the causes of dystonia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Causes of Dystonia

Dystonia has three major etiological categories: genetic/primary forms (most commonly caused by mutations in genes like PRRT2, TOR1A, SGCE, and KMT2B), secondary/acquired forms (resulting from structural brain lesions, medications, or metabolic disorders), and idiopathic forms where no cause is identified.

Primary/Genetic Causes

The genetic landscape of dystonia is extensive, with over 250 genes identified and designated as DYT1-20 for major monogenic forms 1, 2. The most clinically relevant genetic causes include:

Isolated Genetic Dystonias

  • TOR1A (DYT1): Autosomal dominant, typically presents in childhood with limb-onset generalized dystonia, 60-90% penetrance 3, 1
  • THAP1 (DYT6): Autosomal dominant, often involves cranial-cervical regions 2
  • KMT2B: One of the most frequently reported in pediatric forms, involves gene transcription during neurodevelopment 1, 2

Combined Genetic Dystonias

  • GCH1 (DYT5): Dopa-responsive dystonia, dramatic response to levodopa 4
  • SGCE (DYT11): Myoclonus-dystonia syndrome, frequently reported in pediatric cases 1, 4
  • ATP1A3 (DYT12): Rapid-onset dystonia-parkinsonism 4
  • PRRT2: Major causative gene for paroxysmal kinesigenic dyskinesia (PKD), located on chromosome 16p11.2 3

Molecular Pathways Involved

The pathogenic mechanisms cluster around several key pathways 2:

  • Gene transcription during neurodevelopment (KMT2B, THAP1)
  • Calcium homeostasis (ANO3, HPCA)
  • Striatal dopamine signaling (GNAL)
  • Endoplasmic reticulum stress response (EIF2AK2, PRKRA, TOR1A)
  • Autophagy (VPS16)

Secondary/Acquired Causes

Medication-Induced Dystonia

Antipsychotic medications are the most common iatrogenic cause, particularly in children and adolescents who may be at higher risk than adults 5:

  • High-potency dopamine antagonists (haloperidol) produce acute dystonic reactions more frequently 5
  • Acute dystonia involves sudden spastic contraction of neck, eyes (oculogyric crisis), or torso muscles 5, 6
  • Risk factors: Young age, male gender, high-potency agents 5
  • Timing: Usually occurs after first few doses or dose increases 6
  • Laryngeal dystonia is rare but life-threatening, presenting as choking, difficulty breathing, or stridor 6

Structural Brain Lesions

Acquired brain lesions typically affect the putamen, thalamus, or globus pallidus and cause contralateral hemidystonia 4. These can result from:

  • Stroke
  • Trauma
  • Hypoxic-ischemic injury
  • Tumors

Metabolic and Heredodegenerative Disorders

Wilson's disease is a critical treatable cause that must not be missed 7:

  • Presents with dystonic syndrome as one of four neurological patterns (along with akinetic-rigid, pseudosclerosis/tremor, and ataxia)
  • Dystonia can be focal, segmental, or severe with contractures
  • Cranial involvement common: dysarthria, drooling, oropharyngeal dystonia, facial grimacing
  • Often accompanied by psychiatric symptoms in one-third of patients
  • Diagnosis delay can be up to 12 years in neuropsychiatric presentations 7

Other metabolic causes include mitochondrial disorders, which may present during metabolic stress 8.

Neuromuscular Diseases

Dystonia can be a feature in several neuromuscular conditions 9:

  • Myotonic dystrophy (DM1 and DM2): Results from genetic expansion of nucleotide repeats
  • Friedreich ataxia: Associated with basal ganglia dysfunction
  • These conditions show axial dystonia and progressive features

Idiopathic Dystonia

When no genetic cause is identified and no secondary etiology is apparent, dystonia is classified as idiopathic. This represents a significant proportion of cases, particularly in adult-onset focal dystonias 10.

Clinical Classification Framework

Dystonia should be classified along two axes 3, 10:

By Clinical Characteristics:

  • Pure/Isolated: Only dystonic movements present
  • Combined: Dystonia plus other movement disorders (myoclonus, parkinsonism, tremor)
  • Distribution: Focal, segmental, multifocal, or generalized
  • Age of onset: Childhood, adolescence, or adult
  • Temporal pattern: Persistent, action-specific, paroxysmal (as in PKD)

By Etiology:

  • Primary/Genetic: Familial or sporadic with genetic basis
  • Secondary/Acquired: Structural, metabolic, drug-induced
  • Idiopathic: Unknown cause

Critical Diagnostic Pitfalls

  1. Mistaking drug-induced dystonia for psychotic agitation in patients on antipsychotics 5
  2. Confusing neurologic symptoms of Wilson's disease with hepatic encephalopathy in patients with liver disease 7
  3. Missing Wilson's disease in patients presenting with isolated psychiatric symptoms - always consider in young patients with behavioral changes 7
  4. Overlooking paroxysmal forms (PKD) which may have aura and be triggered by sudden movements 3
  5. Failing to recognize atypical features suggesting secondary causes: prominent tongue/perioral involvement, pyramidal signs, ataxia, oculomotor abnormalities, cognitive disturbances 4

Red Flags Requiring Urgent Investigation

  • Elevated creatine kinase (>3× normal) suggesting muscle destruction 8
  • Respiratory insufficiency with generalized weakness 8
  • Loss of motor milestones suggesting neurodegeneration 8
  • Hemolysis with liver disease suggesting Wilson's disease 7
  • Recent medication changes, particularly antipsychotics 5, 6

Pathophysiological Understanding

Dystonia results from dysfunctional networks involving basal ganglia, cerebellum, thalamus, and cortex 2. An emerging concept is that alteration of sensorimotor circuits during crucial developmental windows may contribute to many forms 11. This neurodevelopmental perspective explains why many genetic dystonias present in childhood and stabilize in early adulthood 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.